Tested batch: EP-260520-KP10
KPV is a tripeptide consisting of Lysine-Proline-Valine (Dalmasso et al., 2008). Each box contains 10 vials of lyophilized powder, with 10mg per vial. This peptide is supplied as a research compound for laboratory use only.
Specifications: SKU KPV10 · 10 vials of lyophilised powder per box · 10mg per vial · measured net content 12.14 mg. Testing: four Kovera Labs reports for batch EP-260520-KP10: RP-HPLC purity 98.973% with LC-MS identity, endotoxin < 0.20 EU/mL, heavy metals and sterility – see the certificates below. Further reading: KPV in Australia: product overview and KPV: a research guide to evaluating suppliers. For laboratory research use only; not for human consumption.
Free shipping on all products.
This product is strictly intended for laboratory research use only. Not for human consumption. All products sold are for research purposes and should only be handled by qualified professionals in a controlled laboratory environment.
Tested batch: EP-260520-KP10 · 4 published certificates. Report library updated .
Batch EP-260520-KP10 – four Kovera Labs reports. Purity and identity: RP-HPLC purity 98.973%, net content 12.14 mg, LC-MS identity: KPV (KVR-2026-5E65FB, 16 June 2026). Endotoxin: < 0.20 EU/mL (ENDO-KVR-2026-5E65FB). Heavy metals: lead < 0.5, arsenic < 0.15, cadmium < 0.05 and mercury < 0.3 ppm (HM-KVR-2026-5E65FB). Sterility: no bacterial growth (aerobic and anaerobic) and no fungi or yeast detected after a 2-day incubation (RSTER-KVR-2026-5E65FB). Each certificate links to its Kovera Labs verification record, and the product image shows the same batch reference. For laboratory research use only.
| Test | Reported result | Report ID | Report date |
|---|---|---|---|
| Purity and Identity (COA) | Purity: 98.973 %; Net content: 12.14 mg; Identity confirmation: KPV | KVR-2026-5E65FB | 16 June 2026 |
| Endotoxin | Endotoxin: < 0.20 EU/mL | ENDO-KVR-2026-5E65FB | 30 May 2026 |
| Heavy Metals | Lead: < 0.5 ppm; Arsenic: < 0.15 ppm; Cadmium: < 0.05 ppm; Mercury: < 0.3 ppm | HM-KVR-2026-5E65FB | 31 May 2026 |
| Sterility testing | Bacteria (aerobic/anaerobic): No Growth; Fungi / yeast: Not Detected; Incubation period: 2 days | RSTER-KVR-2026-5E65FB | 30 May 2026 |
Read how to interpret and verify a Kovera Labs report or browse our testing standards and report directory.
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Purity | 98.973 % | — | RP-HPLC |
| Net content | 12.14 mg | — | — |
| Identity confirmation | KPV | — | LC-MS |
| Endotoxin screen | PASS | — | — |
| Microbial sterility screen | No Growth | — | — |
| Arsenic (As) screening | Negative | — | — |
| Cadmium (Cd) screening | Negative | — | — |
| Lead (Pb) screening | Negative | — | — |
| Mercury (Hg) screening | Negative | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Endotoxin | < 0.20 EU/mL | ≤ 0.5 | — |
| Final determination | PASS | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Lead | < 0.5 ppm | ≤ 10 | ICP-MS |
| Arsenic | < 0.15 ppm | ≤ 1.5 | ICP-MS |
| Cadmium | < 0.05 ppm | ≤ 0.5 | ICP-MS |
| Mercury | < 0.3 ppm | ≤ 3 | ICP-MS |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Bacteria (aerobic/anaerobic) | No Growth | — | — |
| Fungi / yeast | Not Detected | — | — |
| Incubation period | 2 days | — | — |
| Temperature | 30-35C | — | — |
| Final determination | SAMPLE PASSES STERILITY SCREEN | — | — |
Evidence reviews and laboratory guides relevant to KPV 10mg, plus the testing behind each batch.
KPV is the tripeptide Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH), a tridecapeptide derived from proopiomelanocortin (Brzoska et al., 2008).
A 2008 review summarised in vitro and animal research on α-MSH and related tripeptides, including KPV (Brzoska et al., 2008). A 2008 study examined how KPV enters cells through the di/tripeptide transporter PepT1, using human intestinal epithelial and T-cell lines and two mouse models of chemically induced colitis, and measured inflammatory signalling and cytokine expression (Dalmasso et al., 2008). These are cell and animal findings; they do not show effects in people.
About the evidence. Findings reported in published studies relate to the materials used in that work. This product is supplied by Eternal Peptides Wholesale for laboratory research use only and is not for human or veterinary use. Its Kovera Labs reports are published on this page and in the COA library.
Explore KPV research, Australian buying guides and laboratory documentation.
